Mayme Wong

2.9k total citations
39 papers, 2.2k citations indexed

About

Mayme Wong is a scholar working on Orthopedics and Sports Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Mayme Wong has authored 39 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Orthopedics and Sports Medicine, 18 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in Mayme Wong's work include Bone health and osteoporosis research (20 papers), Estrogen and related hormone effects (18 papers) and Bone health and treatments (13 papers). Mayme Wong is often cited by papers focused on Bone health and osteoporosis research (20 papers), Estrogen and related hormone effects (18 papers) and Bone health and treatments (13 papers). Mayme Wong collaborates with scholars based in United States, Singapore and Canada. Mayme Wong's co-authors include John L. Stock, Kristine D. Harper, Somnath Sarkar, Bruce Mitlak, Dennis M. Black, K.-Y. Yang, D. T. C. Chua, Sooyong Chua, Tet Sen Howe and Joyce Suang Bee Koh and has published in prestigious journals such as Circulation, Endocrine Reviews and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mayme Wong

39 papers receiving 2.1k citations

Peers

Mayme Wong
Zebulun D. Horowitz United States
Christian Rosenquist Denmark
Roberta J. Secrest United States
Wentao Wu China
Kristel Vandormael United States
J.J. Body Belgium
Chunjun Sheng China
Robin K. Dore United States
Annette Schlemmer Denmark
Zebulun D. Horowitz United States
Mayme Wong
Citations per year, relative to Mayme Wong Mayme Wong (= 1×) peers Zebulun D. Horowitz

Countries citing papers authored by Mayme Wong

Since Specialization
Citations

This map shows the geographic impact of Mayme Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayme Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayme Wong more than expected).

Fields of papers citing papers by Mayme Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayme Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayme Wong. The network helps show where Mayme Wong may publish in the future.

Co-authorship network of co-authors of Mayme Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Mayme Wong. A scholar is included among the top collaborators of Mayme Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayme Wong. Mayme Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Mayme, et al.. (2013). A randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naïve adults with diabetes. Current Medical Research and Opinion. 29(5). 465–473. 3 indexed citations
2.
Eastell, Richard, Peiqi Chen, Kenneth G. Saag, et al.. (2010). Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate. Bone. 46(4). 929–934. 28 indexed citations
3.
Devogelaer, Jean‐Pierre, Robert A. Adler, Chris Recknor, et al.. (2009). Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis. The Journal of Rheumatology. 37(1). 141–148. 44 indexed citations
4.
Vogel, Victor G., Yongming Qu, Mayme Wong, Beth Mitchell, & John L. Mershon. (2009). Incidence of Invasive Breast Cancer in Postmenopausal Women After Discontinuation of Long-Term Raloxifene Administration. Clinical Breast Cancer. 9(1). 45–50. 11 indexed citations
5.
Chen, Peiqi, Paul D. Miller, Neil Binkley, et al.. (2008). Use of Lowest Single Lumbar Spine Vertebra Bone Mineral Density T-Score and Other T-Score Approaches for Diagnosing Osteoporosis and Relationships with Vertebral Fracture Status. Journal of Clinical Densitometry. 11(4). 525–531. 9 indexed citations
6.
Shelly, Wendy, Michael W. Draper, Venkatesh Krishnan, Mayme Wong, & Robert B. Jaffe. (2008). Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings. Obstetrical & Gynecological Survey. 63(3). 163–181. 147 indexed citations
7.
Stovall, Dale W., Wulf H. Utian, Margery Gass, et al.. (2007). The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety. Menopause The Journal of The North American Menopause Society. 14(3). 510–517. 70 indexed citations
8.
Stovall, Dale W., Wulf H. Utian, Margery Gass, et al.. (2007). The Effects of Combined Raloxifene and Oral Estrogen on Vasomotor Symptoms and Endometrial Safety. Obstetrical & Gynecological Survey. 62(9). 591–593. 3 indexed citations
9.
Adachi, Jonathan D., Silvano Adami, Pandurang M. Kulkarni, Mayme Wong, & John L. Stock. (2005). Similar Proportions of Women Lose Bone Mineral Density With Raloxifene or Alendronate Treatment. Journal of Clinical Densitometry. 8(3). 273–277. 6 indexed citations
10.
Qu, Yongming, Mayme Wong, D. Thiébaud, & John L. Stock. (2005). The effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: a secondary analysis of the MORE trial. Current Medical Research and Opinion. 21(12). 1955–1959. 22 indexed citations
11.
Johnell, Olof, Jane A. Cauley, Pandurang M. Kulkarni, Mayme Wong, & John L. Stock. (2004). Raloxifene reduces risk of vertebral fractures and breast cancer in postmenopausal women regardless of prior hormone therapy.. Lund University Publications (Lund University). 5 indexed citations
12.
Silverman, Stuart L., Pierre D. Delmas, Pandurang M. Kulkarni, et al.. (2004). Comparison of Fracture, Cardiovascular Event, and Breast Cancer Rates at 3 Years in Postmenopausal Women with Osteoporosis. Journal of the American Geriatrics Society. 52(9). 1543–1548. 35 indexed citations
13.
Kung, Annie W.C., Hsiang‐Tai Chao, Ko-En Huang, et al.. (2003). Efficacy and Safety of Raloxifene 60 Milligrams/Day in Postmenopausal Asian Women. The Journal of Clinical Endocrinology & Metabolism. 88(7). 3130–3136. 30 indexed citations
14.
Maricic, Michael, Jonathan D. Adachi, Somnath Sarkar, et al.. (2002). Early Effects of Raloxifene on Clinical Vertebral Fractures at 12 Months in Postmenopausal Women With Osteoporosis. Archives of Internal Medicine. 162(10). 1140–1140. 119 indexed citations
15.
Lufkin, Edward G., Mayme Wong, & Chad Deal. (2001). The Role of Selective Estrogen Receptor Modulators in the Prevention and Treatment of Osteoporosis. Rheumatic Disease Clinics of North America. 27(1). 163–185. 26 indexed citations
16.
Wong, Mayme, Maria L. Kireeva, Tatiana V. Kolesnikova, & Lester F. Lau. (1997). Cyr61, Product of a Growth Factor-Inducible Immediate-Early Gene, Regulates Chondrogenesis in Mouse Limb Bud Mesenchymal Cells. Developmental Biology. 192(2). 492–508. 136 indexed citations
17.
Wong, Mayme & Rocky S. Tuan. (1995). Interactive Cellular Modulation of Chondrogenic Differentiation in Vitro by Subpopulations of Chick Embryonic Calvarial Cells. Developmental Biology. 167(1). 130–147. 37 indexed citations
18.
Wong, Mayme & Rocky S. Tuan. (1993). NuSerum, a synthetic serum replacement, supports chondrogenesis of embryonic chick limb bud mesenchymal cells in micromass culture. In Vitro Cellular & Developmental Biology - Animal. 29(12). 917–922. 22 indexed citations
19.
20.
Wong, Mayme & Peter G. Wells. (1988). Effects of N‐acetylcysteine on fetal development and on phenytoin teratogenicity in mice. Teratogenesis Carcinogenesis and Mutagenesis. 8(2). 65–79. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zebulun D. Horowitz Breakdown of academic impact, for papers by Christian Rosenquist Breakdown of academic impact, for papers by Roberta J. Secrest Breakdown of academic impact, for papers by Wentao Wu Breakdown of academic impact, for papers by Kristel Vandormael Breakdown of academic impact, for papers by J.J. Body Breakdown of academic impact, for papers by Chunjun Sheng Breakdown of academic impact, for papers by Robin K. Dore Breakdown of academic impact, for papers by Annette Schlemmer
Rankless by CCL
2026